Qualified institutional researchers looking to buy gonadorelin peptide can source analytical-grade decapeptide directly from PX1 Research. Every lot undergoes rigorous RP-HPLC and ESI-MS testing to guarantee high sequence fidelity, lot-to-lot consistency, and low endotoxin levels for reliable in vitro and preclinical experimentation.
Qualified institutional researchers looking to buy gonadorelin peptide can source analytical-grade decapeptide directly from PX1 Research. Every lot undergoes rigorous RP-HPLC and ESI-MS testing to guarantee high sequence fidelity, lot-to-lot consistency, and low endotoxin levels for reliable in vitro and preclinical experimentation.
When principal investigators and laboratory procurement officers prepare to buy gonadorelin peptide for experimental protocols, sourcing high-purity material backed by lot-specific documentation is essential. Gonadorelin—identical in amino acid sequence to endogenous gonadotropin-releasing hormone (GnRH)—is a synthetic decapeptide utilized extensively in preclinical endocrine, neuroendocrine, and cellular signaling assays.
PX1 Research supplies USA-manufactured gonadorelin research peptide strictly for laboratory research use. Each lot is processed in GMP-compliant facilities and subjected to independent analytical validation by ISO 17025-accredited testing laboratories. Every order ships same-day (Monday through Friday) from our logistics centers in California and Arizona, providing fast fulfillment for academic, biotechnology, and institutional research projects.
Gonadorelin is a linear decapeptide with the defined primary sequence Pyro-Glu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 and an approximate molecular weight of 1182.3 g/mol. The N-terminal pyroglutamic acid residue and C-terminal glycinamide modification are critical structural features that dictate peptide stability, receptor binding kinetics, and enzymatic degradation pathways.
In physiological and in vitro contexts, gonadorelin acts as a selective agonist at the gonadotropin-releasing hormone receptor (GnRH-R), a high-affinity G-protein coupled receptor (GPCR) primary expressed on pituitary gonadotroph cells. Upon ligand binding, GnRH-R triggers Gq/11 protein coupling, activating phospholipase C (PLC) and downstream protein kinase C (PKC) pathways along with intracellular calcium mobilization. Explore our complete catalog of research peptides to compare related neuroendocrine signaling tools.
In preclinical animal models and cell culture preparations, researchers utilize gonadorelin to investigate hypothalamic-pituitary-gonadal (HPG) axis dynamics. Academic literature demonstrates that the frequency and duration of GnRH receptor stimulation dictate downstream transcriptional activity. Pulsatile exposure to gonadorelin in pituitary cell assays stimulates the synthesis and secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH).
Conversely, continuous un-pulsed exposure in preclinical rodent and cell models leads to receptor desensitization, target receptor downregulation, and transient suppression of downstream gonadotropin release. This dual response profile makes gonadorelin a pivotal control molecule in cellular signaling studies, reproductive biology research, and receptor desensitization experiments. Detailed theoretical mechanisms can be explored further in our gonadorelin mechanism breakdown.
Researchers evaluating hypothalamic peptides often compare natural-sequence Gonadorelin against modified synthetic agonist analogs. While native-sequence Gonadorelin exhibits a rapid clearance profile and transient receptor activation kinetics, modified analogues possess amino acid substitutions designed to alter half-life and binding affinity.
For instance, triptorelin peptide incorporates a D-Tryptophan substitution at position 6, significantly enhancing enzymatic stability and receptor binding affinity compared to native gonadorelin. Similarly, non-native synthetic GnRH agonists like leuprolide or buserelin present altered dissociation constants (Kd) and sustained signaling responses in vitro. In contrast, native gonadorelin remains the gold standard control compound for modeling natural pulsatile secretion profiles without the prolonged receptor occupancy characteristic of modified analogues. Review our detailed triptorelin vs gonadorelin comparative study for further biochemical performance data.
Because structural impurities, truncated peptide sequences, or residual TFA (trifluoroacetic acid) can confound cellular assays, verified purity is non-negotiable. PX1 Research enforces strict quality control parameters before releasing any lot of gonadorelin to the scientific community.
Primary verification relies on Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to establish chemical purity (guaranteed ≥98%) and Electrospray Ionization Mass Spectrometry (ESI-MS) to verify exact target molecular mass. Analytical documentation detailing purity percentage, observed mass, and chromatic retention time is publicly accessible for every lot on our research documentation portal.
For cell culture assays, primary gonadotroph isolations, and delicate in vivo animal models, lipopolysaccharide (LPS) bacterial endotoxin contamination can induce non-specific inflammatory signaling pathways, invalidating experimental outcome data. PX1 Research subjects all lyophilized peptide lots to Limulus Amebocyte Lysate (LAL) chromogenic assays.
Our threshold limits ensure endotoxin levels remain strictly controlled (typically <0.01 EU/μg), protecting experimental integrity. High-purity manufacturing processes coupled with sterile lyophilization protocols guarantee that research compounds arrive ready for precision analytical preparation.
Proper handling and preparation of lyophilized peptides are imperative to preserve structural integrity and prevent aggregation. When preparing gonadorelin for laboratory assays, technicians should adhere to standardized aseptic techniques:
1. Centrifuge the vial briefly prior to opening to consolidate the lyophilized cake at the bottom of the container. 2. Reconstitute using sterile bacteriostatic water, sterile 0.9% sodium chloride, or buffer solutions (such as PBS, pH 7.4) appropriate for your specific cell line or analytical apparatus. 3. Gently swirl or invert the vial; avoid vigorous vortexing, which can introduce shear stress and induce peptide denaturation. 4. For comprehensive handling protocols across various peptide classes, review our published peptide reconstitution guide.
Lyophilized gonadorelin should be stored at -20°C for short-term evaluation or -80°C for extended archival preservation, protected from atmospheric moisture and light exposure. In dry, sub-zero conditions, the lyophilized peptide cake remains stable for up to 24 months.
Once reconstituted into aqueous solution, aliquots should be prepared immediately to avoid repeated freeze-thaw cycles, which compromise peptide primary structure. Reconstituted aqueous solutions stored at 2°C to 8°C should generally be utilized within 7 to 14 days, depending on solvent selection and container compatibility.
PX1 Research supports university laboratories, contract research organizations (CROs), and corporate R&D divisions with streamlined supply chain solutions. Institutional procurement teams can access bulk packaging formats, standardized lot reservation, and automated reorder schedules via our wholesale lab account portal.
All institutional orders ship directly from our domestic US facilities (located in California and Arizona), bypassing international customs delays and providing reliable, traceable shipping with full chain-of-custody documentation.
What is the primary research utility of Gonadorelin peptide?
Gonadorelin is utilized in preclinical and in vitro research as a synthetic agonist of the gonadotropin-releasing hormone receptor (GnRH-R) to investigate hypothalamic-pituitary signaling, LH/FSH secretion dynamics, and receptor downregulation kinetics.
How is the purity of PX1 Research Gonadorelin verified?
Every batch of Gonadorelin undergoes independent third-party analytical testing using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity determination (≥98%) and Electrospray Ionization Mass Spectrometry (ESI-MS) for molecular weight confirmation.
What is the difference between native Gonadorelin and Triptorelin?
Gonadorelin features the exact 10-amino-acid native sequence of endogenous GnRH, exhibiting rapid receptor turnover. Triptorelin is a modified synthetic analog featuring a D-Trp substitution at position 6, yielding higher receptor affinity and prolonged enzymatic half-life in analytical assays.
Where is PX1 Research Gonadorelin manufactured and shipped from?
All PX1 Research compounds are manufactured in domestic USA GMP-compliant facilities and shipped directly from fulfillment centers in California and Arizona with same-day shipping on orders placed Monday through Friday.
Are endotoxin test results provided for Gonadorelin lots?
Yes. Each lot undergoes LAL (Limulus Amebocyte Lysate) testing to verify low endotoxin levels (typically <0.01 EU/μg), preventing unwanted inflammatory signaling in cell culture or animal research models.
How should lyophilized Gonadorelin be stored upon receipt?
Desiccated lyophilized vials should be stored at -20°C for routine short-term research or -80°C for long-term storage. Avoid exposure to light, heat, and moisture.
What solvent is recommended for reconstituting Gonadorelin for laboratory assays?
Standard reconstitution reagents include sterile bacteriostatic water, 0.9% sterile saline, or phosphate-buffered saline (PBS, pH 7.4), selected based on specific assay requirements and container compatibility.
Can Gonadorelin be purchased for clinical or medical application?
No. All products offered by PX1 Research, including Gonadorelin, are strictly sold for in vitro laboratory research and preclinical educational use only. They are not intended for human or veterinary medical use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.